SINOVAC BIOTECH LTD Deferred Income Tax Expense (Benefit)
SINOVAC BIOTECH LTD (SVA) reported Deferred Income Tax Expense (Benefit) of -$89.91 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-06-05
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$89.91M 20-F · filed 2026-06-05 | |
| 2024-12-31 | -$56.41M 20-F · filed 2026-06-05 | |
| 2023-12-31 | -$17.41M 20-F · filed 2026-06-05 | $76.32M 20-F · filed 2024-04-29 |
| 2022-12-31 | -$83.63M 20-F · filed 2026-04-30 | -$83.01M 20-F · filed 2023-05-01 |
| 2021-12-31 | $508.50M 20-F · filed 2026-04-30 | $265.10M 20-F · filed 2022-04-29 |
| 2020-12-31 | -$11.23M 20-F · filed 2023-05-01 | |
| 2019-12-31 | -$5.68M 20-F · filed 2022-04-29 | |
| 2018-12-31 | $3.15M 20-F · filed 2021-04-22 | |
| 2017-12-31 | -$4.92M 20-F · filed 2020-04-30 | |
| 2016-12-31 | -$1.01M 20-F · filed 2019-04-29 | |
| 2015-12-31 | -$333.00K 20-F · filed 2018-05-11 | -$518.00K 20-F · filed 2016-04-25 |
| 2014-12-31 | -$225.00K 20-F · filed 2017-11-22 | -$162.00K 20-F · filed 2015-04-29 |
| 2013-12-31 | -$2.23M 20-F · filed 2016-04-25 | |
| 2012-12-31 | -$17.00K 20-F · filed 2015-04-29 | -$17.20K 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $2.85M 20-F · filed 2014-04-16 | $2.85M 20-F · filed 2012-04-12 |
| 2010-12-31 | -$1.71M 20-F/A · filed 2013-05-23 | |
| 2009-12-31 | $1.26M 20-F · filed 2012-04-12 |